Briefing: NMR Reveals Site-Specific Structural Signatures of Therapeutic Antibodies

A new study has introduced a method utilizing NMR technology to analyze monoclonal antibodies, which are essential for treating a range of diseases.

This approach focuses on preserving the three-dimensional structure of these biologic drugs, which is critical for their safety and efficacy.

By eliminating the need for isotope labeling, this non-invasive technique enhances the assessment of antibody structures, potentially impacting future therapeutic developments.